coumarin has been researched along with Prostatic Neoplasms in 12 studies
2H-chromen-2-one: coumarin derivative
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coumarin is an investigational new drug that has produced objective tumor regression in some patients with metastatic renal cell carcinoma and malignant melanoma." | 6.67 | Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma. ( Crawford, ED; Fair, WR; Glode, LM; Gomella, LG; Marshall, ME; Mohler, JL; Zippe, CD, 1992) |
| "Coumarin is an investigational new drug that has produced objective tumor regression in some patients with metastatic renal cell carcinoma and malignant melanoma." | 2.67 | Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma. ( Crawford, ED; Fair, WR; Glode, LM; Gomella, LG; Marshall, ME; Mohler, JL; Zippe, CD, 1992) |
| "In recent years immunotherapy of prostate cancer has developed into an innovative field of investigation." | 2.38 | [Immunotherapy of prostate cancer]. ( Schulze, H; Sommerfeld, HJ, 1993) |
| "Coumarins are a member of the benzopyrone family of compounds with diverse and interesting pharmacological properties." | 1.46 | Identification of 7,8-Diacetoxy-3-Arylcoumarin Derivative as a Selective Cytotoxic and Apoptosis-inducing Agent in a Human Prostate Cancer Cell Line. ( Badisa, VL; Joseph, MY; Latinwo, LM; Musa, MA, 2017) |
| "Coumarin was also shown to possess antimetastatic activity in a Dunning R3327-MatLu tumour model." | 1.29 | Antitumour activity of coumarin in prostate and mammary cancer models. ( Kager, M; Maucher, A; von Angerer, E, 1994) |
| "Coumarin was also shown to possess antimetastatic activity in a Dunning R3327-MatLu tumour model." | 1.29 | Evaluation of the antitumour activity of coumarin in prostate cancer models. ( Kager, M; Maucher, A; von Angerer, E, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lovell, S | 1 |
| Zhang, L | 1 |
| Kryza, T | 1 |
| Neodo, A | 1 |
| Bock, N | 1 |
| De Vita, E | 1 |
| Williams, ED | 1 |
| Engelsberger, E | 1 |
| Xu, C | 1 |
| Bakker, AT | 1 |
| Maneiro, M | 1 |
| Tanaka, RJ | 1 |
| Bevan, CL | 2 |
| Clements, JA | 1 |
| Tate, EW | 1 |
| Musa, MA | 1 |
| Latinwo, LM | 1 |
| Joseph, MY | 1 |
| Badisa, VL | 1 |
| Metcalf, GA | 1 |
| Shibakawa, A | 1 |
| Patel, H | 1 |
| Sita-Lumsden, A | 1 |
| Zivi, A | 1 |
| Rama, N | 1 |
| Ladame, S | 1 |
| Yagoda, A | 1 |
| Petrylak, D | 1 |
| Myers, RB | 1 |
| Parker, M | 1 |
| Grizzle, WE | 1 |
| von Angerer, E | 2 |
| Kager, M | 2 |
| Maucher, A | 2 |
| Mohler, JL | 2 |
| Williams, BT | 1 |
| Thompson, IM | 1 |
| Marshall, ME | 2 |
| Schulze, H | 1 |
| Sommerfeld, HJ | 1 |
| Ghosh, P | 1 |
| Markin, RS | 1 |
| Sorrell, MF | 1 |
| Gomella, LG | 1 |
| Crawford, ED | 1 |
| Glode, LM | 1 |
| Zippe, CD | 1 |
| Fair, WR | 1 |
4 reviews available for coumarin and Prostatic Neoplasms
| Article | Year |
|---|---|
Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Cisplatin; Clinical Trials as Topic; | 1993 |
Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma; Coumarins; Humans; Male; Middle Aged; Prostatic Neoplasms | 1994 |
[Immunotherapy of prostate cancer].
Topics: Antibodies, Monoclonal; Coumarins; Humans; Immunotherapy; Immunotherapy, Active; Immunotherapy, Adop | 1993 |
Coumarin-induced hepatic necrosis.
Topics: Aged; Antineoplastic Agents; Biopsy; Chemical and Drug Induced Liver Injury; Coumarins; Humans; Live | 1997 |
1 trial available for coumarin and Prostatic Neoplasms
| Article | Year |
|---|---|
Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma.
Topics: Adult; Aged; Carcinoma; Coumarins; Drug Evaluation; Humans; Male; Neoplasm Metastasis; Prostatic Neo | 1992 |
7 other studies available for coumarin and Prostatic Neoplasms
| Article | Year |
|---|---|
A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate Cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Resistance, Neoplasm; D | 2021 |
Identification of 7,8-Diacetoxy-3-Arylcoumarin Derivative as a Selective Cytotoxic and Apoptosis-inducing Agent in a Human Prostate Cancer Cell Line.
Topics: Apoptosis; Cell Proliferation; Coumarins; Humans; Male; Membrane Potential, Mitochondrial; Mitochond | 2017 |
Amplification-Free Detection of Circulating microRNA Biomarkers from Body Fluids Based on Fluorogenic Oligonucleotide-Templated Reaction between Engineered Peptide Nucleic Acid Probes: Application to Prostate Cancer Diagnosis.
Topics: Biomarkers; Biosensing Techniques; Circulating MicroRNA; Coumarins; Fluorescent Dyes; Humans; Male; | 2016 |
2nd Proceedings of The International Society of Coumarin Investigators (ISCI). 1,2-Benzopyrone (Coumarin): update on mechanisms of action - Treatment of renal cell carcinoma and prostate cancer - Prevention of melanoma recurrence. Hamburg, Germany, 9 Marc
Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Coumarins; Humans; Kidney Neoplasms; Male; Me | 1994 |
The effects of coumarin and suramin on the growth of malignant renal and prostatic cell lines.
Topics: Carcinoma, Renal Cell; Cell Division; Coumarins; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms | 1994 |
Antitumour activity of coumarin in prostate and mammary cancer models.
Topics: Adenocarcinoma; Animals; Coumarins; Disease Models, Animal; Female; Lung Neoplasms; Male; Mammary Ne | 1994 |
Evaluation of the antitumour activity of coumarin in prostate cancer models.
Topics: Animals; Antineoplastic Agents; Coumarins; Drug Administration Schedule; Drug Screening Assays, Anti | 1993 |